ZUCCHINI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 6.399
AS - Asia 2.837
EU - Europa 2.731
SA - Sud America 403
AF - Africa 59
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.434
Nazione #
US - Stati Uniti d'America 6.264
SG - Singapore 1.128
CN - Cina 888
PL - Polonia 676
RU - Federazione Russa 411
DE - Germania 405
BR - Brasile 339
UA - Ucraina 287
IT - Italia 279
GB - Regno Unito 228
HK - Hong Kong 227
TR - Turchia 190
FI - Finlandia 182
VN - Vietnam 179
CA - Canada 75
FR - Francia 59
IN - India 52
SE - Svezia 52
MX - Messico 44
ID - Indonesia 35
JP - Giappone 34
ES - Italia 29
AR - Argentina 28
ZA - Sudafrica 28
AT - Austria 27
CZ - Repubblica Ceca 26
BD - Bangladesh 23
IQ - Iraq 18
LT - Lituania 18
NL - Olanda 18
BE - Belgio 12
EC - Ecuador 10
PK - Pakistan 9
MA - Marocco 8
IR - Iran 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
EG - Egitto 6
SA - Arabia Saudita 6
CL - Cile 5
JO - Giordania 5
PT - Portogallo 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
UZ - Uzbekistan 4
AU - Australia 3
KR - Corea 3
LB - Libano 3
PY - Paraguay 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
SR - Suriname 1
Totale 12.434
Città #
Ashburn 778
Fairfield 683
Singapore 667
Warsaw 666
Woodbridge 645
Houston 394
Beijing 354
Chandler 343
Jacksonville 313
Santa Clara 275
Seattle 264
Ann Arbor 256
Wilmington 243
Hong Kong 227
Munich 204
Cambridge 198
Los Angeles 134
New York 122
Ferrara 112
Nanjing 106
Izmir 102
Helsinki 87
Dallas 75
Princeton 71
Ho Chi Minh City 65
San Diego 56
Shanghai 55
Milan 52
Hanoi 42
Boardman 38
São Paulo 35
Washington 35
Tokyo 33
Brooklyn 32
Turku 31
Buffalo 28
Jakarta 28
London 27
Orem 27
Denver 26
Chennai 25
Montreal 25
Nanchang 25
Phoenix 25
Boston 23
Chicago 23
Mexico City 23
Hebei 21
Johannesburg 20
Poplar 20
Toronto 20
Moscow 19
Stockholm 19
Vienna 19
Falkenstein 18
Frankfurt am Main 18
Bologna 17
Brno 17
Jiaxing 17
San Francisco 17
Norwalk 16
Shenyang 16
The Dalles 16
Atlanta 15
Auburn Hills 14
Hefei 14
San Jose 14
Dearborn 13
Falls Church 13
Mcallen 13
Ankara 12
Montréal 12
Tianjin 12
Amsterdam 11
Brussels 11
Manchester 11
Mountain View 11
Rio de Janeiro 11
Bremen 10
Changsha 10
Columbus 9
Da Nang 9
Ningbo 9
San Mateo 9
Council Bluffs 8
Dong Ket 8
Guangzhou 8
Guarulhos 8
Mumbai 8
Nuremberg 8
Redwood City 8
Roubaix 8
Wroclaw 8
Ardabil 7
Brasília 7
Jinan 7
Kunming 7
Olomouc 7
Zhengzhou 7
Baghdad 6
Totale 8.751
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 523
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 376
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 352
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 349
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 341
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 278
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 235
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 227
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 221
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 214
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 213
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 209
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 209
Personalized needles for microinjections in the rodent brain 198
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 194
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 194
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 188
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 186
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 184
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 183
Involvement of the neuropeptide orphanin FQ/nociceptin in kainate and kindling seizures and epileptogenesis 182
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 179
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 179
Gene Therapy Tools for Brain Diseases 178
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 176
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 175
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 171
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 170
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 168
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 166
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 160
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 160
Mechanisms of action of CHF3381 in the forebrain 157
Fibroblast Growth Factor-2 (FGF-2). 156
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 156
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 156
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 156
Temporal lobe epilepsy model, neural stem cells and gene therapy 155
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 153
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 152
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 150
Implication of sestrin3 in epilepsy and its comorbidities 150
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 148
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 147
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 142
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 141
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 134
Different patterns of induction of fibroblast growth factor-2 and brain-derived neurotrophic factor messenger RNAs during kindling epileptogenesis, and development of a herpes simplex vector for fibroblast growth factor-2 gene transfer in vivo 131
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 126
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 124
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 117
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 111
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 110
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 108
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 108
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 106
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 102
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 99
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 98
null 97
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 97
Gene therapy of the nervous system by herpes virus vectors 96
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 96
null 94
null 94
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 93
null 93
null 92
Molecular approaches to inhibit HIV-1 tat expression and functions 90
null 89
null 89
null 89
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 81
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells 80
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 74
Possible Approaches of Gene Therapy of AIDS. 73
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 71
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 70
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 69
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 62
null 43
Totale 12.563
Categoria #
all - tutte 53.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.471
Totale 55.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 100 43 113 38 157 113 45
2021/2022742 31 94 61 24 27 28 47 42 20 48 69 251
2022/2023734 74 44 48 75 119 101 38 77 100 4 40 14
2023/2024881 41 46 41 12 48 222 89 97 66 62 50 107
2024/20252.055 55 47 152 114 215 264 86 109 324 157 253 279
2025/20263.188 654 194 397 756 830 357 0 0 0 0 0 0
Totale 12.563